Sacituzumab Govitecan Gains First-Line TNBC Indications

Published Date: 26 Jun 2026

Sacituzumab govitecan is the first ADC approved for upfront metastatic triple-negative breast cancer regardless of PD-L1 inhibitor eligibility.

Read Full News

Latest News

EBay Probes How Banned Gender-Test Kits Available in India

EBay has launched an internal review of its shopping website's safeguards after Reuters flagged that several gender-prediction kits were available for delivery to India.

US Names Acting FDA Drug, Vaccine Chiefs to Permanent Posts

The U.S. health department on Tuesday appointed the acting heads of the FDA's drug and biologics review centers to ⁠permanent roles, formalizing leadership at the two key...

Fetal Size at Birth Tied to Long-Term Academic Performance

Among term-born children, smaller fetal size shows persistent associations with lower academic performance throughout adolescence, whereas gestational age effects fade by early childhood.

Obstetric Unit Closures Double Rural Travel Time

Hospital obstetric unit closures add nearly 14 minutes to travel time for care, with rural communities facing the greatest increases, according to a new study.

His Research on Pregnant Opioid Users Was Celebrated. Experts Found Major Flaws.

Some clinics still use approaches described in Craig Towers' research

Study Offers Reassurance on Inhaled Corticosteroid Use for Asthma in Pregnancy

— Asthma has been linked with adverse outcomes in both mothers and their offspring

Todays Updates

UK Lawmakers Reject Bid to Legalise Assisted Dying

British lawmakers rejected on Friday a proposal to legalise assisted dying for terminally ill people, dealing a major setback to campaigners and bringing the latest effort...

Liberalized Cannabis Policies May Increase Substance Use

In a global review, legalization was associated with increased cannabis use and related emergency department visits, with potential decreases in the use of alcohol and tobacco.

Tissue-Free ctDNA Predicts Recurrence in Early Breast Cancer

Researchers analyzed plasma samples collected from 313 patients with early breast cancer approximately 2 years after they had completed adjuvant chemotherapy.

Can Response-Adapted Surgery Improve Outcomes in HNSCC?

Patients who respond to neoadjuvant immunochemotherapy may be able to undergo less extensive surgery, with high rates of disease control and organ preservation.

TKI Discontinuation Feasible After ALL Treatment

In patients with first- or second-line Philadelphia-positive B-cell acute lymphoblastic leukemia, favorable outcomes are observed with discontinuation of ponatinib.

SBRT Plus Atezolizumab Shows No Benefit in Inoperable NSCLC

For patients with early-stage, inoperable lung cancer, adding atezolizumab to standard radiotherapy boosts toxicity, not survival.

Todays Updates

UK Lawmakers Reject Bid to Legalise Assisted Dying

British lawmakers rejected on Friday a proposal to legalise assisted dying for terminally ill people, dealing a major setback to campaigners and bringing the latest effort...

Liberalized Cannabis Policies May Increase Substance Use

In a global review, legalization was associated with increased cannabis use and related emergency department visits, with potential decreases in the use of alcohol and tobacco.

Tissue-Free ctDNA Predicts Recurrence in Early Breast Cancer

Researchers analyzed plasma samples collected from 313 patients with early breast cancer approximately 2 years after they had completed adjuvant chemotherapy.

Can Response-Adapted Surgery Improve Outcomes in HNSCC?

Patients who respond to neoadjuvant immunochemotherapy may be able to undergo less extensive surgery, with high rates of disease control and organ preservation.

TKI Discontinuation Feasible After ALL Treatment

In patients with first- or second-line Philadelphia-positive B-cell acute lymphoblastic leukemia, favorable outcomes are observed with discontinuation of ponatinib.

SBRT Plus Atezolizumab Shows No Benefit in Inoperable NSCLC

For patients with early-stage, inoperable lung cancer, adding atezolizumab to standard radiotherapy boosts toxicity, not survival.

Latest News

EBay has launched an internal review of its shopping website's safeguards after Reuters flagged that several gender-prediction kits were available for delivery to India.

The U.S. health department on Tuesday appointed the acting heads of the FDA's drug and biologics review centers to ⁠permanent roles, formalizing leadership at the two key...

Among term-born children, smaller fetal size shows persistent associations with lower academic performance throughout adolescence, whereas gestational age effects fade by early childhood.

Hospital obstetric unit closures add nearly 14 minutes to travel time for care, with rural communities facing the greatest increases, according to a new study.

Some clinics still use approaches described in Craig Towers' research

— Asthma has been linked with adverse outcomes in both mothers and their offspring

News All Time

Opioids for Routine Hysterectomies Really Necessary?

More individualized pain prescriptions should be considered, researcher says

Long-Acting Lenacapavir Still Delivered Effective HIV PrEP After a Year

Only one person developed HIV infection in year-long extensions of two PURPOSE trials

Cabotegravir HIV PrEP Effective Among U.S. Women Despite Treatment Interruptions

No cases of incident HIV over more than 1 year of follow-up in OPERA cohort

State's Abortion Drug Law Heightens Hemorrhage Risk for Pregnant Patients

Misoprostol in Louisiana is now kept locked in a secure room

Experts Establish Pillars of Care for Older Adults With HIV

ART iniitiation, managing comorbidities addressed for aging patients

In Lindsay Clancy's Tragedy, I Recognize Something Painfully Familiar

A better model of care is urgently needed for postpartum mental health

Lindsay Clancy's Diary Chronicled Desperation and 'Brain Fog' Before She Killed Kids

"I want help. I want to be well," her attorney read from one journal entry

A Week After Shaving, She Developed Rare Flesh-Eating Disease

Fournier's gangrene followed a perineal shave and application of cream from an alternative healer

Despite Progress in TNBC, More Biomarkers Are Needed to Improve Outcomes

"PD-L1 is clinically useful but imperfect," expert says

Woman Says She Was Wrongly Diagnosed With Cancer, Had Surgery Due to Labeling Error

Atlanta-area patient filed lawsuit against the medical center

Residential Context Matters in Ovarian Cancer Survival

That's especially true for Black women

Debate on Use of SSRIs in Pregnancy Shifting, Experts Say

Researchers push for a focus on shared structured decision-making processes

Infants Possibly Exposed to HIV via Breast Milk Donated Over Social Media

Potentially exposed babies tracked down by investigators all tested negative

Threat Monitoring, Legal Resources: How Hospitals Adapted to Abortion Bans

Institutional standards necessary to give physicians clarity, says researcher

The Doctors Who 'Don't See Pregnant Patients'

Neither pregnancy nor abortion are siloed

This Fetus Had a Parasitic Twin in an Unusual Location

Extremely rare palatal fetus-in-fetu proved challenging for medical team

Recommended News For You

Disparities in use of MRI to detect prostate cancer: Race and location may influence testing

What is Mohs micrographic surgery? 8 FAQs about Mohs

Cancer detection recovered following pandemic disruptions

AI-based liquid biopsy shows promise for detecting brain cancer

Research exposes far-reaching toll of financial hardship on patients with cancer

Ultrasonography of hepatocellular carcinoma: From diagnosis to prognosis

X-ray and radar technology combined to reduce cancer screening risks

Recommended Articles For You

Next-Generation Sequencing in Oncology: Unlocking the Future of Precision Medicine 

Future of Chemotherapy: New Advances, Treatments & Survival Rates Transforming Cancer Care 

Emerging Therapies Using Combination Radiopharmaceutical Platforms for Sequential Tumor Targeting 

Fresh Frozen Plasma: Its Role in Treating Trauma and Bleeding Disorders 

Whats more on Hidoc Dr.

Medical Updates
KOL Videos
Surveys
Events

Daily news to keep you up to date

Gain valuable insights with our in-depth KOL Video discussions

Participate and win cash vouchers

Get updates on the latest events happening around the world
Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Beyond What Is Visible in Myelofibrosis?

2.

MCh in Surgical Oncology: Admission, Medical School, Fees, Qualifications Information

3.

ASCO Future Focus: Follicular Lymphoma: Future Focus from the American Society of Clinical Onology

4.

Fake Cancer Drugs; Let's Talk About Sex; Reducing Cancer-Related Fatigue

5.

In SCLC, Radiotherapy Plus Immunotherapy Ups Fatal Events

1.

Tumor Ecological Stability and Disease Course Evolution

2.

Intrapancreatic Fat, Pancreatitis, and Cancer: Role of Cancer-Associated Fibroblasts

3.

Unlocking the Mysteries of Rhabdomyoma: A New Hope for Treatment

4.

Exploring the Latest Advances in Hodgkin's Lymphoma Treatment

5.

Critical Care Updates on Hematopoietic Dysfunction During Prolonged Critical Illness

1.

International Cancer Conference

2.

Asian Symposium on Advancement in Hematology and Oncology (ASAHO)

3.

International Cancer Conference

4.

Asian Symposium on Advancement in Hematology and Oncology (ASAHO)

5.

Asian Symposium on Advancement in Hematology and Oncology

1.

Virtual Case Study on Pedal Edema and Triple Vessel Disease - An Initiative by Hidoc Dr.

2.

An Eagles View - Evidence-based discussion on Iron Deficiency Anemia- Further Talks

3.

Comprehensive Update on Hematology

4.

Management of 1st line ALK+ mNSCLC (CROWN TRIAL Update) - Part V

5.

Efficient Management of First line ALK-rearranged NSCLC

Fastest Growing Medical Platform for Doctors

Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801

Phone :
+1-415-463-3094

Email :
anishagadia@hidoc.co

Quick Links

Drug DatabaseDrug InteractionDiseases Database
KOL VideosKnowledge HubQuizzes
Medical UpdatesEventsAbout Us

© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
Home
Profile
Login
bot